Display Settings:

Format

Send to:

Choose Destination
    Rev Med Interne. 2008 Sep;29(9):696-700. Epub 2008 Jun 3.

    [Interferon-alpha: a key cytokine in systemic lupus erythematosus pathogenesis].

    [Article in French]

    Source

    Service de médecine interne, centre de référence national pour les lupus et le syndrome des antiphospholipides, CHU Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, 75651 Paris cedex 13, France. alexis.mathian@free.fr

    Abstract

    Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by a chronic inflammation affecting multiple tissues and the production of antibodies directed against nuclear antigens. Leading observations in patients suggested years ago that interferon-alpha (IFNalpha) was involved in SLE pathogenesis. These observations have now been confirmed in SLE-prone mice. New promising therapeutic strategies, aiming at neutralizing IFNalpha or its effects, are currently under development.

    PMID:
    18524426
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk